<?xml version="1.0" encoding="UTF-8"?>
<p>SDS-PAGE was performed under reducing (electrophoretic profile) conditions on a 4–12% precasted-SDS mini gel (MiniProtean III apparatus; Biorad Laboratories Inc, Hercules, CA, USA). Separated bands were transblotted to Hybond membranes (Amersham Biosciences; GE Healthcare, Buckinghamshire, England) under semidry conditions (Transblot apparatus; Biorad). Membranes were stained with the Ponceau S solution (SERVA). Whenever required, protein extracts were concentrated according to the 500 VivaSpin manufacturers’ recommendations (Sartorius AG, Goettingen, Germany). Some samples were subject to IgG removal according to a standard procedure (GE Healthcare) [
 <xref ref-type="bibr" rid="CR31">31</xref>].
</p>
